gastrointestin
gi
symptom
diarrhea
vomit
abdomin
pain
nausea
uncommon
manifest
acut
respiratori
infect
ari
addit
file
report
hallmark
sever
influenza
childhood
influenza
virus
respiratori
agent
human
rhinovirus
hrv
detect
stool
patient
ari
addit
file
correl
gi
symptom
viabil
stool
still
debat
sever
possibl
explan
observ
gi
symptom
ari
first
winter
ari
gastroenter
outbreak
overlap
creat
spuriou
associ
ari
gi
symptom
mayb
caus
coinfect
respiratori
agent
enterovirus
second
gi
symptom
may
side
effect
drug
treatment
antibiot
antivir
food
consumpt
ex
raw
shellfish
mollusc
third
gi
symptom
could
either
manifest
direct
viral
effect
indirect
viral
effect
respiratori
virus
lungderiv
cellinduc
dysbiosi
result
intestin
injuri
insuffici
inform
preval
gi
symptom
ari
clinic
featur
potenti
risk
factor
may
lead
diagnost
error
inadequ
treatment
context
limit
main
object
twoyear
prospect
studi
evalu
demograph
clinic
microbiolog
factor
associ
presenc
gi
symptom
patient
present
gener
practition
gp
ari
repres
sampl
gp
french
sentinel
network
recruit
enrol
ari
patient
mainland
franc
ensur
select
ari
patient
remain
random
gp
requir
includ
week
first
two
patient
seen
consult
met
inclus
criteria
regardless
age
case
definit
ari
person
sudden
onset
symptom
least
one
follow
four
system
symptom
fever
greater
histori
fever
greater
taken
home
feverish
malais
headach
myalgia
least
one
follow
three
respiratori
symptom
cough
sore
throat
short
breath
patient
recruit
within
h
onset
symptom
patient
enrol
gp
two
consecut
ari
season
week
novemb
week
april
week
novemb
april
addit
file
gp
complet
case
report
form
crf
volunt
met
case
definit
agre
particip
submit
post
item
list
addit
file
defin
patient
vaccin
hesh
receiv
least
one
dose
season
influenza
vaccin
least
day
onset
ari
symptom
two
type
sampl
obtain
enrol
patient
nasopharyng
swab
stool
sampl
nasopharyng
specimen
collect
gp
sent
crf
test
laboratori
post
triplepackag
copan
univers
transport
medium
utmrt
contain
copan
italia
brescia
itali
includ
patient
ask
collect
stool
specimen
send
laboratori
within
h
post
tripl
packag
requir
unit
nation
class
specif
nasopharyng
specimen
nucleic
acid
extract
utmstor
sampl
elut
elut
buffer
use
qiaamp
minelut
viru
spin
kit
qiagen
franc
accord
manufactur
instruct
stool
specimen
centrifug
xg
min
nucleic
acid
extract
utmstor
sampl
elut
elut
buffer
use
qiaamp
minelut
viru
spin
kit
qiagen
accord
manufactur
instruct
intern
control
phage
ad
extract
tube
assess
qualiti
extract
end
amplif
extract
sampl
nasopharyng
stool
screen
influenza
b
virus
realtim
quantit
revers
transcript
pcr
rtqpcr
influenza
virusposit
specimen
subtyp
influenza
b
virusposit
sampl
analys
victoria
yamagata
lineag
accord
method
develop
french
nation
influenza
centr
presenc
noninfluenza
respiratori
pathogen
group
analys
rtqpcr
qpcr
use
fast
track
diagnost
ftd
respiratori
pathogen
kit
fast
track
diagnost
luxemburg
use
five
tube
contain
primer
probe
mix
differ
virus
influenza
influenza
subtyp
human
rhinoviru
hrv
influenza
b
human
coronavirus
hcov
hcov
human
parainfluenza
virus
hpiv
intern
control
human
parainfluenza
mycoplasma
pneumonia
mpneu
human
bocaviru
hbov
human
metapneumoviru
hmpv
ab
respiratori
syncyti
viru
rsvab
human
adenoviru
hadv
enteroviru
ev
human
parechoviru
hpev
extract
stool
sampl
screen
rtqpcr
qpcr
use
ftd
viral
gastroenter
kit
fast
track
diagnost
luxemburg
accord
manufactur
instruct
use
three
multiplex
pcr
detect
six
virus
human
noroviru
adenoviru
hadv
human
astroviru
hastv
rotaviru
rv
sapoviru
sav
panel
ftd
bacteri
gastroenter
kit
fast
track
diagnost
luxemburg
use
follow
manufactur
procedur
use
two
multiplex
rtqpcr
six
bacteria
campylobact
colijejunilari
escherichia
coli
verotoxin
posit
salmonella
spp
shigella
spp
enteroinvas
escherichia
coli
yersinia
enterocolitica
clostridium
difficil
two
differ
posit
control
viral
bacteri
multiplex
rtqpcr
reaction
neg
control
tube
provid
kit
quantit
variabl
describ
use
mean
minmax
standard
deviat
compar
wilcoxon
test
qualit
variabl
describ
use
proport
compar
use
chisquar
fisher
exact
test
chisquar
test
applic
result
present
odd
ratio
confid
interv
ci
use
uncondit
logist
regress
model
studi
factor
associ
sgi
ari
patient
yesno
compar
independ
effect
factor
associ
bivari
analys
pvalu
variabl
model
chosen
automat
backward
select
use
signific
level
bivari
multivari
analys
perform
patient
one
pathogen
detect
nasopharyng
swab
andor
stool
sampl
analys
perform
use
r
program
http
wwwrprojectorg
overal
nasopharyng
specimen
patient
posit
least
one
respiratori
pathogen
group
analys
studi
tabl
infect
singl
viru
account
posit
nasopharyng
sampl
wherea
infect
multipl
virus
observ
includ
nine
doubl
infect
advhbov
two
influenza
b
virushcov
two
hcovhrv
two
hrvhbov
one
tripl
infect
hrvadvhrsv
fig
frequent
identifi
pathogen
influenza
viru
consist
influenza
viru
influenza
b
viru
follow
hcov
hrv
rsv
tabl
fig
sampl
test
posit
hcov
factor
list
tabl
analys
investig
associ
gi
symptom
ari
patient
tabl
show
factor
significantli
relat
gi
symptom
ari
patient
result
rnadna
posit
stool
ari
patient
without
gi
symptom
respiratori
pathogen
test
also
report
tabl
ari
patient
report
least
one
gi
symptom
associ
presenc
high
fever
adjust
odd
ratio
aor
confid
interv
ci
p
headach
aor
p
tabl
ari
patient
gi
symptom
like
least
one
enter
infect
aor
p
detect
stool
infect
hcov
detect
nasopharynx
aor
p
tabl
proport
gi
symptom
ari
patient
singl
infect
rang
hrv
infect
nasopharyng
swab
enter
pathogen
infect
stool
specimen
tabl
ari
patient
hcov
detect
nasopharynx
enter
pathogen
detect
stool
statist
like
gi
symptom
ari
patient
respiratori
pathogen
infect
tabl
among
ari
patient
laboratoryconfirm
influenza
least
nasopharynx
gi
symptom
tabl
consumpt
antipyret
medic
consult
seem
reduc
risk
develop
gi
symptom
popul
aor
p
tabl
studi
result
show
presenc
gi
symptom
ari
patient
could
explain
detect
respiratori
pathogen
stool
howev
gi
symptom
common
among
patient
ari
exclus
infect
hcov
detect
nasopharyng
sampl
associ
explain
presenc
hcov
stool
simultan
detect
hcov
nasopharyng
stool
specimen
sporad
even
associ
gi
symptom
enter
infect
surpris
interest
point
ari
infect
gi
symptom
associ
laboratoryconfirm
enter
infect
result
suggest
gi
symptom
patient
ari
could
relat
enter
infect
posit
correl
gi
symptom
fever
headach
observ
studi
increas
difficulti
clinic
diagnosi
detect
hcov
nasopharyng
sampl
patient
ari
result
line
previou
studi
report
hcov
respiratori
sampl
ari
patient
present
studi
patient
hcov
featur
ari
patient
gi
symptom
moreov
patient
hcov
infect
declar
gi
symptom
although
hcov
recogn
caus
respiratori
infect
role
gastrointestin
infect
remain
uncertain
subject
debat
present
studi
gi
symptom
posit
associ
singl
laboratoryconfirm
hcov
infect
detect
nasopharynx
ari
patient
associ
explain
presenc
hcov
stool
simultan
detect
hcov
nasopharyng
stool
specimen
observ
four
patient
four
commonli
circul
hcov
detect
stool
sampl
thu
none
four
hcov
could
specif
associ
posit
stool
proport
hcov
stool
specimen
less
import
nasopharyng
specimen
versu
respect
hamper
effici
comparison
result
limit
interpret
moreov
ari
patient
present
hcov
stool
absenc
hcov
nasopharynx
therefor
presenc
hcov
rna
stool
like
due
swallow
rather
due
local
replic
gi
tract
presenc
hcov
nasopharynx
seem
link
gi
symptom
ari
patient
biolog
mechan
remain
unclear
line
previou
studi
associ
observ
season
influenza
viru
detect
nasopharyng
stool
sampl
gi
symptom
ari
patient
howev
among
patient
influenza
infect
present
gi
symptom
mous
model
use
wang
show
influenza
infect
mechan
depend
type
interferon
ifni
alter
composit
intestin
microbiota
result
immunolog
dysregul
may
promot
inflammatori
gut
disord
number
escherichia
coli
ecoli
intestin
tract
increas
perhap
lead
intestin
immun
injuri
similar
studi
report
influenzainduc
ifni
enhanc
suscept
salmonella
intestin
colon
dissemin
secondari
salmonellainduc
coliti
suppress
host
intestin
immun
system
role
ifni
alter
intestin
microbi
balanc
influenza
infect
need
explor
interestingli
found
consumpt
antipyret
drug
consult
seem
reduc
risk
develop
gi
symptom
among
laboratoryconfirm
influenza
patient
result
line
previou
studi
show
paracetamol
dramat
decreas
morbid
associ
influenza
therebi
reduc
clinic
symptom
associ
influenza
viru
infect
therefor
consumpt
antipyret
drug
consult
may
lead
underestim
frequenc
gi
symptom
patient
laboratoryconfirm
influenza
strength
studi
includ
prospect
multicentr
design
studi
length
span
two
consecut
ari
season
standard
patient
screen
particip
gp
central
confirm
microbiolog
data
simultan
search
respiratori
pathogen
nasopharyng
stool
sampl
presenc
enter
pathogen
virus
bacteria
stool
confound
factor
might
also
caus
gi
symptom
studi
sever
limit
first
main
limit
studi
lack
cultur
respiratori
virus
stool
sampl
determin
rtqpcr
detect
repres
presenc
viabl
viru
detect
respiratori
virus
stool
could
simpli
rnadna
virus
swallow
recent
studi
show
swallow
viru
could
detect
stool
protect
mechan
render
resist
gastric
acid
bilepancreat
juic
high
viscos
mucu
could
protect
influenza
virus
inactiv
gastrointestin
environ
account
detect
viru
fece
second
number
patient
includ
allow
identif
meaning
associ
subanalys
studi
smalltomoder
sampl
size
employ
logist
regress
report
overestim
effect
measur
third
collect
data
pertain
gi
symptom
gp
consult
hamper
interpret
result
conclus
except
ari
patient
enter
pathogen
stool
sampl
presenc
gi
symptom
ari
patient
could
explain
detect
respiratori
pathogen
stool
howev
detect
enter
pathogen
stool
sampl
could
explain
presenc
gi
symptom
ari
case
biolog
mechan
explain
associ
presenc
hcov
nasopharynx
gi
symptom
need
explor
